METTL3 and breast carcinoma: In breast cancer, Li et al. discovered that circMETTL3, with upregulated expression due to METTL3-induced m6A modification, could bind miR-31-5p and increase CDK1 expression, promoting breast cancer cels proliferation and metastasis [29].